Correspondence 0000950170-24-037920 from BIOLASE, INC (BIOL) (CIK 0000811240)
BIOLASE, INC (BIOL) (CIK 0000811240)
Date: March 28, 2024 · CIK: 0000811240 · Accession: 0000950170-24-037920
AI Filing Summary & Sentiment
File numbers found in text: 333-276280
Letter
BIOLASE, Inc.
27042 Towne Centre Drive, Suite 270
Lake Forest, California 92610
(949) 361-1200
March 28, 2024
VIA EDGAR
United States Securities and Exchange Commission Division of Corporation Finance
100 F Street, N.E. Washington, D.C. 20549
Re:
BIOLASE, Inc.
Registration Statement on Form S-1, as amended
File No: 333-276280
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
BIOLASE, Inc. (the “Registrant”) hereby requests that the United States Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1, as amended (File No. 333-276280), to become effective on Tuesday, April 2, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
The Registrant understands that the Staff of the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
The Registrant hereby authorizes its counsel, Leslie Marlow, Esq. or Patrick J. Egan, Esq. of Blank Rome LLP, to orally modify or withdraw this request for acceleration. Please contact Ms. Marlow at (212) 885-5358 or Mr. Egan at (212) 885-5346 with any questions you may have concerning this request, and please notify either Ms. Marlow or Mr. Egan when this request for acceleration has been granted.
Very truly yours,
BIOLASE, INC.
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
BIOLASE, Inc.
27042 Towne Centre Drive, Suite 270
Lake Forest, California 92610
(949) 361-1200
March 28, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
BIOLASE, Inc.
Registration Statement on Form S-1, as amended
File No: 333-276280
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
BIOLASE, Inc. (the “Registrant”) hereby requests that the United States Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1, as amended (File No. 333-276280), to become effective on Tuesday, April 2, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
The Registrant understands that the Staff of the Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the federal securities laws as they relate to the issuance of the securities covered by the Registration Statement.
The Registrant hereby authorizes its counsel, Leslie Marlow, Esq. or Patrick J. Egan, Esq. of Blank Rome LLP, to orally modify or withdraw this request for acceleration. Please contact Ms. Marlow at (212) 885-5358 or Mr. Egan at (212) 885-5346 with any questions you may have concerning this request, and please notify either Ms. Marlow or Mr. Egan when this request for acceleration has been granted.
Very truly yours,
BIOLASE, INC.
By:
/s/ John R. Beaver
Name: John R. Beaver
Title: Chief Executive Officer
cc:
Leslie Marlow, Esq., Blank Rome LLP
Patrick J. Egan, Esq., Blank Rome LLP